On-Target Side Effects of Targeted Therapeutics of Cancer by József Tímár, Andrea Uhlyarik

Get full text

KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges by Judit Moldvay, Judit Moldvay, József Tímár

Get full text

Editorial: Pathology and Oncology Research: addressing publication ethics issues by József Tímár, Andrea Ladányi, Anna Sebestyén, László Kopper, László Kopper

Get full text

Microsatellite instability and mismatch repair protein deficiency: equal predictive markers? by Maja L. Nádorvári, Gábor Lotz, Janina Kulka, András Kiss, József Tímár

Get full text

Comparison of standard mismatch repair deficiency and microsatellite instability tests in a large cancer series by Maja L. Nádorvári, István Kenessey, András Kiss, Tamás Barbai, Janina Kulka, Erzsébet Rásó, József Tímár

Get full text

Identification of genetic fingerprint of type I interferon therapy in visceral metastases of melanoma by Laura Vízkeleti, Orsolya Papp, Viktória Doma, Jeovanis Gil, György Markó-Varga, Szonja A. Kovács, Balázs Győrffy, Sarolta Kárpáti, József Tímár

Get full text

Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreatic cancer by Eszter Molnár, Marcell Baranyi, Marcell Baranyi, Krisztina Szigeti, Luca Hegedűs, Fanni Bordás, Zsófia Gábriel, Gréta Petényi, József Tóvári, Balázs Hegedűs, Balázs Hegedűs, József Tímár

Get full text

Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cells. by Tamás Garay, István Kenessey, Eszter Molnár, Éva Juhász, Andrea Réti, Viktória László, Anita Rózsás, Judit Dobos, Balázs Döme, Walter Berger, Walter Klepetko, József Tóvári, József Tímár, Balázs Hegedűs

Get full text

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures by Miklos Diossy, Zsofia Sztupinszki, Judit Borcsok, Marcin Krzystanek, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Jozsef Timar, István Csabai, Janos Fillinger, Judit Moldvay, Anders Gorm Pedersen, David Szuts, Zoltan Szallasi

Get full text

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas by Melinda Varadi, Nikolett Nagy, Henning Reis, Boris Hadaschik, Christian Niedworok, Orsolya Modos, Attila Szendroi, Jason Ablat, Peter C. Black, David Keresztes, Anita Csizmarik, Csilla Olah, Nadine T. Gaisa, Andras Kiss, Jozsef Timar, Erika Toth, Erzsebet Csernak, Arpad Gerstner, Vinay Mittal, Sofia Karkampouna, Marianna Kruithof de Julio, Balazs Gyorffy, Gabor Bedics, Michael Rink, Margit Fisch, Peter Nyirady, Tibor Szarvas

Get full text